The recognition of several new types of non-Hodgkin’s nosis of NHL was confirmed in 1,378 (98.2%) of the cases. The most common lymphoma types were diffuse large Blymphoma (NHL) in recent years has led to proposals for changing lymphoma classifications, including a new procell lymphoma (31%) and follicular lymphoma (22%), whereas the new entities comprised 21% of the cases. Diagposal put forth ...

The recognition of several new types of non-Hodgkin’s nosis of NHL was confirmed in 1,378 (98.2%) of the cases. The most common lymphoma types were diffuse large Blymphoma (NHL) in recent years has led to proposals for changing lymphoma classifications, including a new procell lymphoma (31%) and follicular lymphoma (22%), whereas the new entities comprised 21% of the cases. Diagposal put forth ...

The recognition of several new types of non-Hodgkin's lymphoma (NHL) in recent years has led to proposals for changing lymphoma classifications, including a new proposal put forth by the International Lymphoma Study Group (ILSG). However, the clinical significance of the new entities and the practical utility of this new proposal have not been studied. Therefore, we performed a clinical evaluat...

The recognition of several new types of non-Hodgkin’s nosis of NHL was confirmed in 1,378 (98.2%) of the cases. The most common lymphoma types were diffuse large Blymphoma (NHL) in recent years has led to proposals for changing lymphoma classifications, including a new procell lymphoma (31%) and follicular lymphoma (22%), whereas the new entities comprised 21% of the cases. Diagposal put forth ...

non-hodgkin's lymphoma is the 3rd most common cancers in children. in the present study, to determine pathological and clinical features of this cancer, we reviewed records of 84 cases of non-hodgkin's lymphoma who were admitted to ali asghar and bahrami children hospitals from 1989 to 1996. 59% of cases had small non-cleaved cell (sncc) subtype of disease. 15% were lymphoblastic and ...

Background: To understand the role of sporadic mutations in the tumor suppressor gene p53 (also known as TP53) in the pathogenesis of breast cancer, it is important to identify at which histologic stage such mutations first occur. We previously showed that a p53 mutation present in invasive breast cancer was found in all surrounding areas of ductal carcinoma in situ (DCIS) but not in areas of h...

BACKGROUND To understand the role of sporadic mutations in the tumor suppressor gene p53 (also known as TP53) in the pathogenesis of breast cancer, it is important to identify at which histologic stage such mutations first occur. We previously showed that a p53 mutation present in invasive breast cancer was found in all surrounding areas of ductal carcinoma in situ (DCIS) but not in areas of hy...